Breaking News Instant updates and real-time market news.

PRU

Prudential

$86.11

1.12 (1.32%)

, BTI

British American Tobacco

$34.45

0.09 (0.26%)

16:03
10/09/19
10/09
16:03
10/09/19
16:03

Prudential to increase life insurance prices for vapers, Bloomberg says

Prudential (PRU) intends to change its policy for customers who vape, saying they'll be classified as smokers instead of non-smokers when applying for individual policies, according to Bloomberg. Publicly traded companies in the space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM).

PRU

Prudential

$86.11

1.12 (1.32%)

BTI

British American Tobacco

$34.45

0.09 (0.26%)

MO

Altria Group

$42.37

0.35 (0.83%)

PM

Philip Morris

$77.37

1.01 (1.32%)

IMBBY

Imperial Brands

$0.00

(0.00%)

  • 09

    Oct

  • 10

    Oct

  • 05

    Nov

  • 12

    Nov

PRU Prudential
$86.11

1.12 (1.32%)

09/12/19
09/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) assumed with a Hold from Buy at Canaccord with analyst Joseph Vafi saying the stock will continue to react to changes in payment volume growth, which has been showing steady deceleration. 2. Deere (DE) and Caterpillar (CAT) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Prudential (PRU) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Alex Scott saying Voya Financial (VOYA) has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential. 4. Invesco (IVZ) downgraded to Neutral from Overweight at JPMorgan with analyst Kenneth Worthington saying continued Oppenheimer outflows "show few signs of slowing," making it unlikely for the stock to outperform despite a cheap valuation. 5. DXC Technology (DXC) was downgraded to In Line from Outperform at Evercore ISI and to Neutral from Positive at Susquehanna. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/19
ATLE
08/08/19
DOWNGRADE
ATLE
Neutral
Prudential downgraded to Neutral from Overweight at Atlantic Equities
09/12/19
GSCO
09/12/19
DOWNGRADE
Target $99
GSCO
Buy
Prudential downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Alex Scott removed Prudential Financial (PRU) from his firm's Americas Conviction List while maintaining a Buy rating on the shares. The analyst also lowered his price target for the stock to $99 from $107. Voya Financial (VOYA) has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential, Scott tells investors in a research note. While a good amount "near-term negativity" is already priced into Prudential, the shares do not have many catalysts in the next six months outside of earnings beats, adds the analyst. He sees a more challenging near-term setup for Prudential and shifts his conviction to Voya.
09/12/19
GSCO
09/12/19
UPGRADE
Target $68
GSCO
Conviction Buy
Voya Financial upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Alex Scott added Voya Financial (VOYA) to his firm's Americas Conviction List while maintaining a Buy rating on the shares. He also raised his price target for the shares to $68 from $59. Voya has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential Financial (PRU), Scott tells investors in a research note. He believes expense reduction, share count reduction, and the addition of a large record keeping contract earn in can drive the upside for Voya.
BTI British American Tobacco
$34.45

0.09 (0.26%)

08/28/19
JPMS
08/28/19
NO CHANGE
JPMS
Neutral
Philip Morris selloff on Altria merger talks overdone, says JPMorgan
JPMorgan analyst Celine Pannuti views the selloff in shares of Philip Morris (PM) following confirmation of the company's merger talks with Altria Group (MO) as overdone. The deal leads to value accretion at no premium and U.S. regulatory risks are already embedded in the sector de-rating, Pannuti tells investors in a research note. The analyst also sees the weakness in British American Tobacco (BTI) shares as a buying opportunity. The consideration of a merger between Philip Morris and Altria is a vote of confidence in the U.S. combustibles profit pool, contrary to current market sentiment, says Pannuti. The analyst keeps a Neutral rating on Philip Morris with an $86 price target.
08/27/19
SBSH
08/27/19
NO CHANGE
SBSH
Citi sees no antitrust reason to stop Philip Morris, Altria deal
Citi analyst Adam Spielman is surprised by the merger talks between Philip Morris (MO) and Altria Group (MO) but feels the deal is likely to go ahead as he sees no antitrust reason to stop it. With the combined company likely a stronger competitor, the potential deal is not a positive for both British American Tobacco (BTI) and Imperial Brands (IMBBY), Spielman tells investors in a research note.
07/16/19
WELS
07/16/19
NO CHANGE
WELS
Wells says Nielsen restatement could be positive for Monster, tobacco stocks
Wells Fargo analyst Bonnie Herzog noted that Nielsen (NLSN) just announced that it will restate data to address serious issues with its calculation methodology in the convenience store channel related to projections it applied to independent c-stores. The restated data, to be released on August 20, is expected to improve cigarette and energy drink trends and she views this as a positive for tobacco stocks and Monster Beverage (MNST). Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
09/12/19
SBSH
09/12/19
NO CHANGE
SBSH
E-vapor regulation to hit Juul hard, 'odd time' for merger talks, says Citi
The Trump Administration said yesterday that it will "clear" the market of all non-tobacco flavored e-vapor products, including mint and menthol, Citi analyst Adam Spielman tells investors in a research note. The analyst had hoped the rules would have little impact on Juul as it has stopped supplying fruit flavors to physical stores. However, Trump's proposal is likely to hit Juul hard, as about three-quarter of its volume is in mint, says Spielman. Further, he believes at least half of British American Tobacco's (BTI) and IImperial Brands' (IMBBY) e-vapor volumes in the U.S. will be banned under the new definition. This all reinforces that this is an "odd time" for Philip Morris (PM) and Altria Group (MO) to be in merger talks, contends Spielman. The analyst, who doubts Trump's announcement will affect the talks between the companies, says the future of tobacco regulation in the U.S. is unclear currently. "We can only assume the companies have chosen to talk now because they are very confident about the outcomes. We, by contrast, see plenty of risk," writes Spielman.
MO Altria Group
$42.37

0.35 (0.83%)

09/24/19
MSCO
09/24/19
NO CHANGE
Target $44
MSCO
Equal Weight
Altria could rise 20%+ if deal an acquisition, not merger, says Morgan Stanley
Morgan Stanley analyst Pamela Kaufman said she expects Philip Morris (PM) and Altria Group (MO) to announce the outcome of their merger talks in the coming weeks. If the deal is confirmed as an all-stock merger of equals consistent with media reports, which she attributes a 70% probability of happening, than she expects Altria shares to be flat at about $41 per share. In a scenario where the companies end talks to merge without a deal, Kaufman sees Altria shares rising about 8% as she calculates a $44 price target for the standalone business assuming its stake in Juul is worth $8.5B, or about two-thirds of the price paid. She sees 20% odds of this scenario. In a third scenario, a deal is financed through a combination of debt and equity. She believes Philip Morris could pay $50 per share for Altria and generate 18%-20% EPS accretion by 2022. In that last scenario, she sees 22% upside potential for Altria shares, though Kaufman only gives such a deal a 10% chance of happening. Kaufman maintains an Equal Weight rating with a $44 price target on Altria shares.
09/26/19
WELS
09/26/19
NO CHANGE
WELS
Wells Fargo not surprised Philip Morris, Altria Group ended merger talks
Wells Fargo analyst Bonnie Herzog says that while she is dismayed by the announcement that Philip Morris (PM) and Altria (MO) have ended merger talks, she is not all that surprised given the length of negotiations and the litany of negative FDA/health headlines throughout. The analyst expects the stocks to trade up sharply since "clearly the market wasn't in favor of this combination." Herzog adds that it appears to her the talks fell apart over JUUL and the companies announced they have agreed to focus on launching iQOS in the U.S. "as part of their mutual interest to achieve a smoke free future." The analyst continues to believe Philip Morris/Altria have a competitive advantage, especially in this environment, with iQOS. She continues to "strongly recommend" both stocks, with Philip Morris remaining her top stock pick.
10/01/19
BOFA
10/01/19
UPGRADE
Target $96
BOFA
Buy
Philip Morris upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Lisa Lewandowski upgraded Philip Morris (PM) to Buy with a price target of $96 after the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. The analyst notes that the whole industry may be impacted by uncertainty around vaping, but she sees Philip Morris rising above the "noise" due to its lack of vaping exposure, strong underlying fundamentals, and potential for offering alternatives to vaping products.
10/07/19
WELS
10/07/19
NO CHANGE
WELS
Outperform
Altria Group's competitive moat widens with iQOS, says Wells Fargo
Wells Fargo analyst Bonnie Herzog reiterates an Outperform rating on Altria Group following her private tour of the new iQOS store/formats that launched in Atlanta. The analyst says that her discussions with the company's management reinforced her belief that iQOS holds a distinct competitive advantage in the U.S. given it's the only RRP authorized by the FDA that will also be allowed to sell mint/menthol flavors in the event the FDA clears the market of non-tobacco flavor variants. While it is hard to say how long it could take others to win FDA authorization, given it took iQOS about two years, Herzog believes the FDA's standard is high. As such, she sees the removal of e-cigarette flavors only widening iQOS' competitive moat.
PM Philip Morris
$77.37

1.01 (1.32%)

10/01/19
10/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Buy from Hold at Canaccord with analyst Michael Walkley saying since the Q2 earnings report, Ericsson has announced deals with Nex-Tech, RINA, and KDDI, demonstrating continuing 5G momentum. 2. VMware (VMW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Philip Winslow saying investors have been concerned that growing interest in deploying containerized applications into Kubernetes-centric environments will eventually reduce customer demand for VMware's virtualization-centric product portfolio. 3. Tradeweb Markets (TW) upgraded to Overweight from Equal Weight at Barclays with analyst Jeremy Campbell saying recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity." 4. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underperform at BofA/Merrill with analyst Christopher Carey saying the bar on the company's earnings consensus may be "too low." 5. Philip Morris (PM) upgraded to Buy from Neutral at BofA/Merrill with analyst Lisa Lewandowski citing the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/19
BOFA
10/01/19
UPGRADE
BOFA
Buy
Philip Morris upgraded to Buy from Neutral at BofA/Merrill
IMBBY Imperial Brands
$0.00

(0.00%)

03/28/19
SBSH
03/28/19
UPGRADE
SBSH
Buy
Imperial Brands upgraded to Buy from Neutral at Citi
Citi analyst Adam Spielman upgraded Imperial Brands to Buy from Neutral and raised his price target for the shares to GBP 30 from GBP 27. The analyst believes organic revenue growth for tobacco companies will pick up this year as sales of next generation products accelerate. Further, the regulatory threat will probably move away from cigarettes, Spielman tells investors in a research note. He thinks an even greater focus on e-vapor cigarettes could be positive for both British American Tobacco and Imperial Brands.
05/28/19
SBSH
05/28/19
NO CHANGE
SBSH
Cigarette data from Nielsen 'dire,' industry data also 'very bad,' says Citi
Citi analyst Adam Spielman noted that Nielsen reported earlier today that cigarette industry volumes fell 11.2% in the four weeks ended May 18, noting that shares of Altria (MO), British American Tobacco (BTI) and Imperial (IMBBY) all fell following the "dire" data. Volumes in MSAi, the industry database that he regards as much more reliable than Nielsen, were down 6.4% in the same period, which Spielman said "is still a very bad figure, but it is a lot, lot better than the Nielsen one." Looking ahead, the analyst said he expects "gradually less bad" volumes in Nielsen in the rest of the year, though he noted that Altria has said it expects industry volumes to fall about 4%-5% this year and he forecasts a decline of about 6%. In late afternoon trading, Altria shares are down 4.5%, British American has declined over 4% and Philip Morris (PM) is down 5%.

TODAY'S FREE FLY STORIES

C

Citi

$72.11

0.03 (0.04%)

12:42
10/23/19
10/23
12:42
10/23/19
12:42
Periodicals
Judge says Citi claim against Czech miner OKD is eligible, Reuters says »

A Czech court determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

ALXN

Alexion

$105.68

6.46 (6.51%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Recommendations
Alexion analyst commentary  »

Piper a buyer of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

SHI

Sinopec Shanghai

$28.18

-0.44 (-1.54%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Upgrade
Sinopec Shanghai rating change  »

Sinopec Shanghai upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
10/23/19
10/23
12:40
10/23/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SFTBF

SoftBank

$0.00

(0.00%)

, WE

We Company

$0.00

(0.00%)

12:38
10/23/19
10/23
12:38
10/23/19
12:38
Periodicals
WeWork's Claure tells staff layoffs are in the works, Reuters says »

Marcelo Claure,…

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

, RHHBY

Roche

$0.00

(0.00%)

12:36
10/23/19
10/23
12:36
10/23/19
12:36
Periodicals
Trump to nominate Stephen Hahn as FDA commissioner, WSJ reports »

President Trump intends…

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$86.51

-0.32 (-0.37%)

GSK

GlaxoSmithKline

$43.27

0.76 (1.79%)

AZN

AstraZeneca

$44.61

0.69 (1.57%)

SNY

Sanofi

$45.54

0.23 (0.51%)

PFE

Pfizer

$36.63

0.19 (0.52%)

MRK

Merck

$82.39

1.09 (1.34%)

LLY

Eli Lilly

$106.97

-3.03 (-2.75%)

JNJ

Johnson & Johnson

$130.13

0.95 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 11

    Nov

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:32
10/23/19
10/23
12:32
10/23/19
12:32
Syndicate
Hexo announces C$70M private placement of convertible debentures »

Hexo Corp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

CRM

Salesforce

$145.02

2.75 (1.93%)

12:30
10/23/19
10/23
12:30
10/23/19
12:30
Options
Heavy delta short term call buyer in Salesforce »

Heavy delta short term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

DYMEF

DionyMed Brands

$0.00

(0.00%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Hot Stocks
DionyMed Brands receives court application seeking to appoint receiver »

DionyMed Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$785.08

-46.605 (-5.60%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Periodicals
Hedgeye sees 30% downside in Chipotle, adds to Best Idea Short List 

Reported by Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BA

Boeing

$340.95

3.5 (1.04%)

, CAT

Caterpillar

$133.30

-0.39 (-0.29%)

12:28
10/23/19
10/23
12:28
10/23/19
12:28
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been a bit…

BA

Boeing

$340.95

3.5 (1.04%)

CAT

Caterpillar

$133.30

-0.39 (-0.29%)

TXN

Texas Instruments

$120.05

-8.56 (-6.66%)

LLY

Eli Lilly

$106.95

-3.05 (-2.77%)

FB

Facebook

$184.57

2.3 (1.26%)

ADI

Analog Devices

$106.03

-4.88 (-4.40%)

MCHP

Microchip

$93.22

-3.09 (-3.21%)

XLNX

Xilinx

$94.81

-1.2 (-1.25%)

NXPI

NXP Semiconductors

$104.12

-3.62 (-3.36%)

TNK

Teekay Tankers

$2.21

0.22 (11.06%)

WGO

Winnebago

$46.96

4.17 (9.75%)

TMO

Thermo Fisher

$296.86

15.97 (5.69%)

SNAP

Snap

$13.22

-0.78 (-5.57%)

REZI

Resideo

$9.06

-6.11 (-40.28%)

LRN

K12

$20.03

-4.81 (-19.36%)

CMG

Chipotle

$784.15

-47.535 (-5.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 07

    Dec

SPLK

Splunk

$117.82

7.41 (6.71%)

12:25
10/23/19
10/23
12:25
10/23/19
12:25
Options
Splunk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$297.03

16.14 (5.75%)

12:23
10/23/19
10/23
12:23
10/23/19
12:23
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/19
10/23
12:17
10/23/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/19
10/23
12:16
10/23/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.60

-0.27 (-1.51%)

12:15
10/23/19
10/23
12:15
10/23/19
12:15
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PYPL

PayPal

$95.85

-1.55 (-1.59%)

, SYF

Synchrony

$34.88

-0.1 (-0.29%)

12:14
10/23/19
10/23
12:14
10/23/19
12:14
Earnings
Fly Intel: What to watch in PayPal earnings report »

PayPal (PYPL) is…

PYPL

PayPal

$95.85

-1.55 (-1.59%)

SYF

Synchrony

$34.88

-0.1 (-0.29%)

V

Visa

$171.35

0.46 (0.27%)

MA

MasterCard

$260.61

-0.69 (-0.26%)

FB

Facebook

$184.50

2.23 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 21

    Nov

F

Ford

$9.04

-0.025 (-0.28%)

12:00
10/23/19
10/23
12:00
10/23/19
12:00
Options
Large pre-earnings calendar spread in Ford ahead of earnings »

Large pre-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TXN

Texas Instruments

$120.29

-8.32 (-6.47%)

11:50
10/23/19
10/23
11:50
10/23/19
11:50
Options
Aggressive post-earnings put seller in Texas Instruments »

Aggressive post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

, FB

Facebook

$185.39

3.12 (1.71%)

11:48
10/23/19
10/23
11:48
10/23/19
11:48
Periodicals
Bitcoin falls amid Zuckerberg testimony on Facebook's Libra, Bloomberg says »

Bloomberg's Claire…

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

FB

Facebook

$185.39

3.12 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

11:47
10/23/19
10/23
11:47
10/23/19
11:47
General news
President Trump says lifting sanctions on Turkey with ceasefire to be permanent »

President Trump announced…

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$41.57

0.84 (2.06%)

11:45
10/23/19
10/23
11:45
10/23/19
11:45
Options
Zscaler call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

11:45
10/23/19
10/23
11:45
10/23/19
11:45
General news
Treasury's $20 B 2-year FRN was awarded at a high discount margin of 0.300% »

Treasury's $20 B…

SDC

SmileDirectClub

$10.19

0.685 (7.21%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Recommendations
SmileDirectClub analyst commentary  »

Guggenheim says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HEXO

Hexo

$2.54

-0.05 (-1.93%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Hot Stocks
Breaking Hot Stocks news story on Hexo »

Hexo Corp trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.